Our analysis shows that ITGA5 mRNA expression increases in invasive lung squamous carcinoma compared with carcinoma in situ; despite it is contrary to the outcome from GEPIA database, ITGA5 is still identified as a risk factor for survival of patients with LUSC in our study. Here, ITGA5 is linked to cancer.